Medically reviewed by Dr. Jaramillo, a doctor at Goodweigh. Last updated on 7 October 2026
Short answer from Dr. Jaramillo
‘Ozempic face’ is a collective term for a gaunt face following significant weight loss. It is not a recognised side effect, but a well-known consequence of significant weight loss, even without medication. Loss of facial volume does not recover on its own, as subcutaneous fat pads do not regenerate spontaneously following weight loss. You can minimise this by not losing weight too quickly. Eating and drinking well (ensuring sufficient protein intake) can help maintain the skin’s elasticity, but true restoration of volume requires medical or dermatological guidance.
Dr. Jaramillo, doctor at Goodweigh
Want to find out more? Start your intake here
Many people who lose weight with GLP-1 medication notice that their face changes. Their cheeks become more hollow and their skin feels looser. Online, this is known as the ‘Ozempic face’. You can read about what it is, what causes it, what you can do about it and whether it comes back.
What exactly is Ozempic face?
‘Ozempic face’ is not a medical diagnosis, but a popular term for facial changes following significant weight loss. These include sunken cheeks, deeper creases on either side of the nose and sagging skin.
The term originated on social media, not from clinical research. ‘Ozempic face’ is not a recognised side effect of Wegovy, Mounjaro or Saxenda. However, a literature review on skin quality describes facial volume loss, thinner skin and reduced levels of collagen and elastin in users of GLP-1 agents. The evidence comes from studies of varying designs, including individual patient reports.
What causes a gaunt appearance when taking GLP-1 medicines?
A gaunt appearance is caused by the fact that you also lose fat in your face and your skin does not always shrink at the same rate. With Wegovy, Mounjaro and Saxenda, the weight lost consists mainly of fat.
A retrospective study using CT and MRI scans examined twenty patients before and after treatment with a GLP-1 agonist. The volume in the midface decreased on average, and the superficial volume decreased more markedly the more weight a person lost. For every 10 kilograms lost, this amounted to approximately 7 per cent less volume in the midface. The study was small and had no control group, so this is an indication rather than an established risk.
This is not unique to GLP-1 medication. Excess skin is also common following stomach reduction surgery (bariatric surgery), according to the NHG Standard on Obesity. This also applies to the face. Following significant weight loss, sagging tissue and less elastic skin on the face and neck can make you look older.
Does muscle loss also play a part?
When you lose weight, you lose not only fat but also some fat-free mass. This is not the same as muscle: it also includes organs, bone and fluid, as explained in a review on fat-free mass in relation to GLP-1 agents.
In that review, the proportion of fat-free mass in the weight lost varies considerably between studies. A meta-analysis of 20 studies showed that this proportion is roughly the same for GLP-1 agonists and for weight loss achieved through lifestyle changes. Loss of lean body mass is therefore a common feature of significant weight loss in general, with or without medication. The evidence shows that weight loss with GLP-1 medication leads to a reduction in facial fat pads and does not result in changes to the facial muscles.
Does this apply to all GLP-1 medicines?
Yes, it’s mainly about the amount of weight you lose, rather than any one particular medicine. This applies to semaglutide (Ozempic, Wegovy and Rybelsus), tirzepatide (Mounjaro) and liraglutide (Saxenda).
For all three, the weight lost consists mainly of fat, as stated in the package leaflets for Wegovy, Mounjaro and Saxenda. In the meta-analysis, the proportion of fat-free mass was slightly higher with semaglutide than with tirzepatide and liraglutide. There is no evidence that one drug alters facial appearance more than another. You can read more about these medicines under Ozempic, Wegovy, Mounjaro, Saxenda and Rybelsus.
Where on your face is Ozempic face most noticeable?
The face changes most noticeably in areas where fat and skin determine its volume, such as the cheeks. People also mention the jawline and the area around the eyes. Too little is known about changes to the nose and eyes to comment on them.
The review on skin quality shows that the changes are not limited to the cheeks: the skin itself also becomes thinner and less elastic. The extent to which this affects you varies from person to person.
How can you minimise Ozempic face?
The most important thing is to lose weight gradually: a review cites rapid weight loss as a risk factor for more pronounced skin changes. The dose of GLP-1 medication is increased gradually to minimise gastrointestinal side effects. Our doctors also use this gradual increase to prevent you from losing weight too quickly.
Strength training helps to maintain muscle mass. A review on strength training in conjunction with incretin-based medicines states that supervised training can promote muscle growth in people in general. In that review, insufficient protein intake is also identified as a risk factor, but it has not been proven whether protein or exercise protects the face. Tips on protein-rich foods for weight loss and the best sports for weight loss will help you get started. You can also read about what to eat whilst taking GLP-1 medication.
Also, make sure you drink plenty of fluids, as this is important when taking Wegovy to prevent dehydration. The review does not specifically assess retinoids or sunburn, but it does recommend early dermatological support and hydration to help maintain healthy skin during GLP-1 treatment.
Is Ozempic face reversible?
Not on its own. Loss of facial volume does not recover on its own, as subcutaneous fat pads do not regenerate spontaneously following weight loss. True restoration of volume requires medical or dermatological guidance. If you have any concerns about your face, discuss with your doctor what is right for you.
Regaining weight is not the answer. You should therefore also read about what happens when you stop taking Ozempic. Some people opt for cosmetic procedures such as fillers. This is a personal choice that you should discuss with a doctor or specialist, and is not part of our treatment.
Is Ozempic face dangerous, and when should you see your doctor?
A gaunt face is primarily an aesthetic issue and not a dangerous side effect. Do, however, contact your doctor if you lose weight very quickly, are barely eating or start to experience any symptoms.
Hair loss is another visible change. Hair loss was reported more frequently with Wegovy than with a placebo, particularly when there was significant weight loss. Hair loss is also listed in the patient information leaflet for Mounjaro. You should discuss how quickly you lose weight with your doctor or coach. You can read about how the programme works under How it works.
Ozempic face in perspective
Quellen
- Sharma, R. K., Vittetoe, K. L., Barna, A. J., Takkouche, S., Varelas, A. N., Yang, S. F., Stephan, S. J., & Patel, P. N. (2025). Radiographic midfacial volume changes in patients on GLP-1 agonists. Otolaryngology-Head and Neck Surgery, 173(2), 360-366. https://pubmed.ncbi.nlm.nih.gov/40407186/
- Neeland, I. J., Linge, J., & Birkenfeld, A. L. (2024). Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. Diabetes, Obesity and Metabolism, 26(Suppl 4), 16-27. https://pubmed.ncbi.nlm.nih.gov/38937282/
- Eisa, N., & Barood, O. (2026). Lean mass changes with incretin therapy versus lifestyle intervention: A systematic review and meta-analysis of randomised controlled trials. Diabetes, Obesity and Metabolism, 28(6), 4818-4827. https://pubmed.ncbi.nlm.nih.gov/41877354/
- Locatelli, J. C., Costa, J. G., Haynes, A., Naylor, L. H., Fegan, P. G., Yeap, B. B., & Green, D. J. (2024). Incretin-based weight loss pharmacotherapy: Can resistance exercise optimize changes in body composition? Diabetes Care, 47(10), 1718-1730. https://pubmed.ncbi.nlm.nih.gov/38687506/
- Barone, M., Brunetti, B., D'Emilio, R., Caputo, M. G., Tenna, S., & Persichetti, P. (2026). Effects of GLP-1 receptor agonists on skin quality: A comprehensive literature review. Aesthetic Plastic Surgery, 50(13), 5403-5407. https://pubmed.ncbi.nlm.nih.gov/42162206/
- Waltzman, J. T., Zins, J. E., & Couto, R. A. (2019). Face and neck lifting after weight loss. Clinics in Plastic Surgery, 46(1), 105-114. https://pubmed.ncbi.nlm.nih.gov/30447822/
- European Medicines Agency. Wegovy: productinformatie. https://www.ema.europa.eu/nl/documents/product-information/wegovy-epar-product-information_nl.pdf
- European Medicines Agency. Mounjaro: productinformatie. https://www.ema.europa.eu/nl/documents/product-information/mounjaro-epar-product-information_nl.pdf
- European Medicines Agency. Saxenda: productinformatie. https://www.ema.europa.eu/nl/documents/product-information/saxenda-epar-product-information_nl.pdf
Frequently Asked Questions
A gaunt appearance can occur following significant weight loss, with or without medication. It is not a dangerous side effect. You may be able to minimise the risk by losing weight gradually, eating and drinking well, and discussing your pace with your healthcare professional. If you’d like to know how much weight you can expect to lose on average, read about how much weight you lose with Ozempic or how many kilos you lose per month.No. ‘Ozempic face’ is not a recognised side effect. It is a collective term for facial changes that may be associated with significant weight loss.
You can limit it, but not eliminate it entirely. It is recommended that you lose weight gradually, eat and drink well, and discuss the pace with your doctor. Our doctors also use a gradual increase in dosage to prevent losing weight too quickly.
No, not on its own. Loss of facial volume does not recover spontaneously, as subcutaneous fat pads do not regenerate following weight loss. True restoration of volume requires medical or dermatological supervision. Discuss this with your doctor if it is a cause for concern.
Yes, that’s possible. It mainly depends on how much weight you lose, not on any one particular medicine.
Discuss this with your doctor or coach, especially if you’re losing weight quickly.



